10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
20.81
-0.83 (-3.84%)
At close: Mar 6, 2026, 4:00 PM EST
20.93
+0.12 (0.58%)
After-hours: Mar 6, 2026, 7:50 PM EST

Company Description

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits.

It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample.

This platform includes HD WT panel gene expression, and HD 3’ gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides.

In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents.

Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns.

The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions.

The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014.

10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics, Inc.
10x Genomics logo
Country United States
Founded 2012
IPO Date Sep 12, 2019
Industry Health Information Services
Sector Healthcare
Employees 1,178
CEO Serge Saxonov

Contact Details

Address:
6230 Stoneridge Mall Road
Pleasanton, California 94588-3260
United States
Phone 925 401 7300
Website 10xgenomics.com

Stock Details

Ticker Symbol TXG
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $39.00
CIK Code 0001770787
CUSIP Number 88025U109
ISIN Number US88025U1097
Employer ID 45-5614458
SIC Code 3826

Key Executives

Name Position
Dr. Serge Saxonov Ph.D. Co-Founder, Chief Executive Officer and Director
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer and Director
Adam S. Taich Chief Financial Officer, Treasurer, Principal Financial Officer and Principal Accounting Officer
Jim Goodrich Chief of Global Operations
Michael Schnall-Levin Ph.D. Founding Scientist and Chief Technology Officer
Cassie Corneau Manager of Investor Relations and Strategic Finance
Dr. Randy Wu General Counsel and Secretary
Mennah Moustafa Chief Commercial Officer
Jens Durruthy Associate Director of Product Management

Latest SEC Filings

Date Type Title
Mar 6, 2026 SCHEDULE 13G/A Filing
Mar 2, 2026 144 Filing
Feb 25, 2026 144 Filing
Feb 23, 2026 144 Filing
Feb 23, 2026 144 Filing
Feb 23, 2026 144 Filing
Feb 13, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 13, 2026 10-K Annual Report
Feb 12, 2026 8-K Current Report
Jan 12, 2026 8-K Current Report